Skip to main content
87598 search results for:

Colorectal Cancer 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 08-04-2024 | Colorectal Cancer | Online First

    Investigating the role of county-level colorectal cancer screening rates on stage at diagnosis of colorectal cancer in rural Georgia

    Colorectal cancer (CRC) is the one of most common cancer diagnoses and cancer-related causes of death in Georgia with an estimated 38.6 cases and 14.1 deaths per 100,000 populations in 2023 [ 1 , 2 ]. Rural communities commonly experience greater …

  2. 26-04-2024 | Online First

    Prognostic factors in pulmonary metastases resection from colorectal cancer: impact of right-sided colon cancer and early recurrence

    In colorectal cancer (CRC), the lung is the second most common site of metastases after the liver, with pulmonary metastases (PM) occurring in approximately 10%–15% of patients [ 1 ] Many studies have demonstrated that PM resection improves …

  3. Open Access 01-12-2024 | Colorectal Cancer | Erratum

    Correction to: 16 S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population

  4. Open Access 01-12-2024 | Colorectal Cancer | OriginalPaper

    Hazard function analysis of prognosis after recurrent colorectal cancer

    Colorectal cancer is one of the most common, malignant diseases and the second most frequent cause of cancer-related death worldwide [ 1 ]. The cumulative recurrence rate is reportedly around 20% [ 2 ], and surgical resection is the standard …

  5. 15-04-2024 | Colorectal Cancer | Online First

    Fruit but not vegetable consumption is beneficial for low prevalence of colorectal polyps in a high-risk population: findings from a Chinese Lanxi Pre-colorectal Cancer Cohort study

    Colorectal cancer (CRC) is a prevalent cancer worldwide, with over 1.9 million new cases reported and ranking as the second leading cause of cancer-related deaths, as documented by a secondary analysis of global cancer statistics in 2020 [ 1 ].

  6. Open Access 01-12-2024 | OriginalPaper

    SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis

    Colorectal cancer (CRC) ranks the second most commonly diagnosed cancer and the third-highest cause of cancer-related deaths worldwide [ 1 ]. Remarkably, at the time of diagnosis, 10–30% of CRC patients present with distant metastasis, with …

  7. Open Access 26-04-2024 | Online First

    Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients

    Colorectal cancer (CRC) is one of the most common malignancies in the Western world [ 1 ], ranking as the second leading cause of cancer-related death [ 2 ]. Although colonoscopy represents the gold standard for CRC screening and diagnosis, the …

  8. Open Access 25-04-2024 | Colorectal Cancer | Online First

    Development and Validation of a Colorectal Cancer Prediction Model: A Nationwide Cohort-Based Study

    Colorectal cancer (CRC) is the third most common cancer worldwide [ 1 ] and one of the leading causes of cancer-related mortality in Europe and the United States [ 2 ]. Early diagnosis of CRC is crucial to enhancing the success of treatment …

  9. Open Access 01-12-2024 | Colorectal Cancer | OriginalPaper

    C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer

    Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related deaths. Despite improvements in survival rates, metastatic CRC remains a lethal disease, with a 5-year survival rate of approximately …

  10. 20-04-2024 | Colorectal Cancer | Online First

    Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer

    Reevaluation of Fruquintinib's Cost-Effectiveness: The study’s findings suggest that fruquintinib, following price reductions and policy changes in China, should be reassessed for its cost-effectiveness in treating refractory metastatic colorectal

  11. 23-04-2024 | Colorectal Cancer | Online First

    Reply to: Colorectal Cancer Screening and Social Vulnerability Index: Impact of COVID-19 Pandemic

  12. 18-04-2024 | Colorectal Cancer | Online First

    Nativity Disparities in Colorectal Cancer Screening Among Hispanics in the United States

    Hispanics in the United States (U.S.) have previously exhibited lower guideline-concordant colorectal cancer (CRC) screening uptake than non-Hispanic (NH) Whites, with disparities accentuated in foreign-born Hispanics, however it is unclear …

  13. 09-03-2024 | Colorectal Cancer | OriginalPaper

    Colorectal cancer information avoidance is associated with screening adherence

    Colorectal cancer (CRC) is the fourth most common cancer among U.S. men and women and the second deadliest. Effective screening modalities can either prevent CRC or find it earlier, but fewer than two thirds of U.S. adults are adherent to CRC …

  14. 09-04-2024 | Colorectal Cancer | Online First

    Dexmedetomidine promotes colorectal cancer progression via Piwil2 signaling

    Dexmedetomidine (DEX), a highly selective α 2 -adrenoceptor agonist, is commonly used during cancer surgeries for both sedation and analgesia. Recent clinical data suggest that perioperative use of DEX is associated with cancer metastasis and …

  15. Open Access 01-12-2024 | Colorectal Cancer | OriginalPaper

    The incidence of early onset colorectal cancer in Aotearoa New Zealand: 2000–2020

    Colorectal cancer (CRC) is the second most common cancer in Aotearoa New Zealand in both men and women; it is second only to prostate and breast cancers, with 3,515 colorectal cancers diagnosed in Aotearoa New Zealand in 2020. It remains the …

  16. Open Access 01-12-2024 | Colorectal Cancer | OriginalPaper

    External validation of the colorectal cancer risk score LiFeCRC using food frequency questions in the HUNT study

    Nearly half of all cancer cases globally are attributable to modifiable risk factors [ 1 ]. Colorectal cancer (CRC) has been identified as being among the most preventable cancers, by being attributable to certain behavioural, occupational …

  17. Open Access 01-12-2024 | Colorectal Cancer | ReviewPaper

    miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression

    Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although …

  18. Open Access 26-04-2024 | Online First

    Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model

    During the past decade, the field of immuno-oncology has dramatically advanced. Variety of immunotherapy approaches are introduced to the clinic to enhance durable immunity against solid tumours. However, high immunotoxicity and low immunogenicity …

  19. 18-04-2024 | Colorectal Cancer | Online First

    PPP2CA Inhibition Promotes Ferroptosis Sensitivity Through AMPK/SCD1 Pathway in Colorectal Cancer

    Colorectal cancer (CRC) is a very common malignant tumor in the digestive system, ranking 4th (6.1% of cases) and 2nd (9.2% of deaths) in terms of incidence and mortality, respectively [ 1 ]. Although surgery is currently the main choice of …

  20. Open Access 01-12-2024 | Colorectal Cancer | OriginalPaper

    Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China

    Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related mortality [ 1 ]. Based on the age at diagnosis, CRC can be classified as the early-onset colorectal cancer (EOCRC), which is diagnosed …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.